1. Home
  2. OSBC vs MNKD Comparison

OSBC vs MNKD Comparison

Compare OSBC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old Second Bancorp Inc.

OSBC

Old Second Bancorp Inc.

N/A

Current Price

$24.65

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$3.29

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSBC
MNKD
Founded
1981
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
OSBC
MNKD
Price
$24.65
$3.29
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
★ $28.33
$7.84
AVG Volume (30 Days)
495.0K
★ 4.6M
Earning Date
10-21-2026
11-04-2026
Dividend Yield
★ 1.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.02
N/A
Revenue
N/A
★ $348,966,000.00
Revenue This Year
$14.40
$26.86
Revenue Next Year
$3.03
$13.64
P/E Ratio
$24.37
★ N/A
Revenue Growth
N/A
★ 22.23
52 Week Low
$16.65
$2.23
52 Week High
$26.06
$6.51

Technical Indicators

Market Signals
Indicator
OSBC
MNKD
Relative Strength Index (RSI) 44.58 37.41
Support Level $23.99 $3.24
Resistance Level $25.95 $4.23
Average True Range (ATR) 0.43 0.22
MACD -0.00 -0.01
Stochastic Oscillator 50.00 11.85

Price Performance

Historical Comparison
OSBC
MNKD

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: